Solventum Corporation (SOLV) Income Statement
SOLV 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSOLV revenue and net income
Where SOLV's revenue goes
2025Each bar shows an amount and its share of revenue. SOLV kept 18.7% of revenue as net income.
SOLV profit margins
SOLV growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +0.9% | +0.8% | +2.7% | — |
| Gross profit | −3.1% | −1.8% | +0.6% | — |
| Operating income | +110.5% | +8.8% | +8.8% | — |
| Net income | +224.8% | +5.0% | +6.5% | — |
| EPS (diluted) | −8.8% | −7.8% | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SOLV quarterly EPS vs estimates
Solventum beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 5, 2026 (estimate $1.35).
SOLV income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $8.32B | $8.25B | $8.20B | $8.13B | $8.17B | $7.28B |
| Cost of revenue | $3.87B | $3.66B | $3.50B | $3.44B | $3.25B | $2.97B |
| Gross profit | $4.45B | $4.59B | $4.69B | $4.70B | $4.92B | $4.32B |
| Research & development | $739.0M | $775.0M | $758.0M | $767.0M | $766.0M | $719.0M |
| Sales, general & admin | $3.08B | $2.78B | $2.32B | $2.23B | $2.28B | $2.17B |
| Total operating expenses | $2.27B | $3.56B | $3.00B | $3.00B | $3.04B | $2.88B |
| Operating income | $2.18B | $1.04B | $1.69B | $1.69B | $1.88B | $1.43B |
| Interest expense | $347.0M | $367.0M | $0 | $0 | — | — |
| Income before taxes | $1.71B | $605.0M | $1.67B | $1.69B | $1.88B | $1.44B |
| Income taxes | $157.0M | $127.0M | $321.0M | $349.0M | $422.0M | $302.0M |
| Net income | $1.56B | $479.0M | $1.35B | $1.34B | $1.46B | $1.14B |
| EBITDA | $2.55B | $1.53B | $2.23B | $2.27B | $2.48B | $2.03B |
| EPS (diluted) | $6.10 | $6.69 | $2.31 | $7.79 | — | — |
| Gross margin | 53.5% | 55.6% | 57.3% | 57.7% | 60.2% | 59.3% |
| Operating margin | 26.2% | 12.6% | 20.6% | 20.8% | 23.0% | 19.6% |
| Net margin | 18.7% | 5.8% | 16.4% | 16.5% | 17.9% | 15.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.21B | $2.01B | $2.00B | $2.10B | $2.16B | $2.07B | $2.08B | $2.08B | $2.08B | $2.02B | $2.04B | $2.07B |
| Cost of revenue | $923.0M | $910.0M | $1.01B | $919.0M | $986.0M | $956.0M | $956.0M | $917.0M | $944.0M | $844.0M | $878.0M | $865.0M |
| Gross profit | $1.29B | $1.10B | $985.0M | $1.18B | $1.18B | $1.11B | $1.12B | $1.17B | $1.14B | $1.17B | $1.16B | $1.21B |
| Research & development | $178.0M | $189.0M | $176.0M | $183.0M | $189.0M | $193.0M | $199.0M | $189.0M | $192.0M | $195.0M | $190.0M | $180.0M |
| Sales, general & admin | $927.0M | $827.0M | $759.0M | $780.0M | $772.0M | $769.0M | $784.0M | $701.0M | $701.0M | $596.0M | $575.0M | $581.0M |
| Total operating expenses | $1.10B | $1.02B | −$693.0M | $1.04B | $961.0M | $962.0M | $983.0M | $890.0M | $893.0M | $791.0M | $752.0M | $705.0M |
| Operating income | $181.0M | $81.0M | $1.68B | $137.0M | $214.0M | $152.0M | $136.0M | $275.0M | $244.0M | $381.0M | $406.0M | $504.0M |
| Interest expense | $64.0M | $62.0M | $51.0M | $89.0M | $103.0M | $104.0M | $107.0M | $107.0M | $114.0M | $39.0M | — | $0 |
| Income before taxes | $108.0M | $16.0M | $58.0M | $1.51B | $103.0M | $38.0M | $13.0M | $167.0M | $96.0M | $329.0M | $391.0M | $500.0M |
| Income taxes | $15.0M | $3.0M | −$5.0M | $248.0M | $13.0M | −$99.0M | −$17.0M | $45.0M | $7.0M | $92.0M | $119.0M | $40.0M |
| Net income | $92.0M | $13.0M | $63.0M | $1.27B | $90.0M | $137.0M | $31.0M | $122.0M | $89.0M | $237.0M | $272.0M | $460.0M |
| EBITDA | $305.0M | $213.0M | $226.0M | $1.72B | $328.0M | $271.0M | $270.0M | $407.0M | $343.0M | $507.0M | $530.0M | $644.0M |
| EPS (diluted) | $2.55 | $1.48 | $1.57 | $1.50 | $1.69 | $1.34 | $1.41 | $1.64 | $1.56 | $2.08 | $2.31 | — |
| Gross margin | 58.2% | 54.7% | 49.3% | 56.2% | 54.4% | 53.8% | 53.9% | 56.0% | 54.6% | 58.1% | 56.9% | 58.3% |
| Operating margin | 8.2% | 4.0% | 84.0% | 6.5% | 9.9% | 7.3% | 6.6% | 13.2% | 11.7% | 18.9% | 19.9% | 24.3% |
| Net margin | 4.2% | 0.6% | 3.2% | 60.4% | 4.2% | 6.6% | 1.5% | 5.9% | 4.3% | 11.8% | 13.4% | 22.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SOLV's financial statements (latest annual report filed February 27, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SOLV financial results
In fiscal year 2025 (ended December 31, 2025), Solventum reported revenue of $8.3 billion, up 0.9% from the year before. It had net income of $1.6 billion (up 224.8%), a net profit margin of 18.7%. Diluted earnings per share came to $6.10. Over five years revenue grew at an average rate of 2.7% a year.
See the SOLV stock overview for the latest quote and news, or the SOLV chart for price history and technical indicators.
SOLV income statement FAQ
What is Solventum's annual revenue?
Solventum reported total revenue of $8.3 billion for fiscal year 2025, which ended on December 31, 2025. That was up 0.9% from $8.3 billion the previous year.
Is Solventum profitable?
Yes. Solventum reported net income of $1.6 billion in fiscal 2025, a net profit margin of 18.7%; its operating margin was 26.2%.
What is Solventum's gross margin?
Solventum's gross margin was 53.5% in fiscal 2025: for every $100 of revenue, Solventum kept $53 after the direct cost of its products and services.
How much does Solventum spend on research and development?
Solventum spent $739.0 million on research and development in fiscal 2025, 8.9% of revenue.
How fast is Solventum growing?
Revenue grew 2.7% a year on average over the last five fiscal years, from $7.3 billion to $8.3 billion.
What are Solventum's earnings per share?
Solventum earned $6.10 per diluted share in fiscal 2025, compared with $6.69 a year earlier.
When will Solventum report its next earnings?
Solventum is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes.
When does Solventum's fiscal year end?
Solventum's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 27, 2026.